137 related articles for article (PubMed ID: 34014587)
21. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
[TBL] [Abstract][Full Text] [Related]
22. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with
Luchtel RA; Dasari S; Oishi N; Pedersen MB; Hu G; Rech KL; Ketterling RP; Sidhu J; Wang X; Katoh R; Dogan A; Kip NS; Cunningham JM; Sun Z; Baheti S; Porcher JC; Said JW; Jiang L; Hamilton-Dutoit SJ; Møller MB; Nørgaard P; Bennani NN; Chng WJ; Huang G; Link BK; Facchetti F; Cerhan JR; d'Amore F; Ansell SM; Feldman AL
Blood; 2018 Sep; 132(13):1386-1398. PubMed ID: 30093402
[TBL] [Abstract][Full Text] [Related]
23.
Savage KJ; Slack GW
Haematologica; 2023 Jun; 108(6):1463-1467. PubMed ID: 36453106
[No Abstract] [Full Text] [Related]
24. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
[TBL] [Abstract][Full Text] [Related]
25. Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.
Osakada A; Fujimoto M; Ueshima C; Kaku Y; Nishikori M; Inoue N; Takeuchi K; Haga H
Pathol Int; 2023 Sep; 73(9):456-462. PubMed ID: 37530485
[TBL] [Abstract][Full Text] [Related]
26. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
27. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
Yuan CT; Cheng AL; Hou HA
Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
Fadl A; Oishi N; Shi M; Dasari S; Ansell SM; Ketterling RP; Feldman AL
Hum Pathol; 2023 Nov; 141():6-14. PubMed ID: 37633531
[TBL] [Abstract][Full Text] [Related]
29. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Anderson J; Putnam E; Liu W; Menon MP
Int J Lab Hematol; 2022 Feb; 44(1):67-68. PubMed ID: 34019742
[No Abstract] [Full Text] [Related]
30. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
[TBL] [Abstract][Full Text] [Related]
31.
Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Ketterling RP; Bedroske PP; Luoma IM; Sattler CA; Boddicker RL; Bennani NN; Nørgaard P; Møller MB; Steiniche T; d'Amore F; Feldman AL
Blood; 2017 Jul; 130(4):554-557. PubMed ID: 28522440
[No Abstract] [Full Text] [Related]
32. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
Magaki S; Satyadev R; Chen Z; Yung KS; Vinters HV; Kinney MC; Said JW
Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
[TBL] [Abstract][Full Text] [Related]
33. Lymphomatoid papulosis with 6p25.3 rearrangement: a further case of the newly described variant.
Kluk J; Child F; Robson A
Br J Dermatol; 2014 Dec; 171(6):1590-2. PubMed ID: 24804939
[No Abstract] [Full Text] [Related]
34. Secondary cutaneous involvement by systemic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma with 6p25.3 rearrangement.
Feldman AL; Grogg KL; Knudson RA; Inwards DJ
Histopathology; 2015 Dec; 67(6):932-5. PubMed ID: 25930107
[No Abstract] [Full Text] [Related]
35. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.
Onaindia A; Montes-Moreno S; Rodríguez-Pinilla SM; Batlle A; González de Villambrosía S; Rodríguez AM; Alegre V; Bermúdez GM; González-Vela C; Piris MA
Histopathology; 2015 May; 66(6):846-55. PubMed ID: 25131361
[TBL] [Abstract][Full Text] [Related]
36. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22.
Csikesz CR; Knudson RA; Greipp PT; Feldman AL; Kadin M
J Invest Dermatol; 2013 Jun; 133(6):1680-2. PubMed ID: 23337887
[No Abstract] [Full Text] [Related]
38. DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway.
Zhao XD; Huang C; Wang RX; Wang SA
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7819-7825. PubMed ID: 30536326
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
40. Vesicular Lymphomatoid Papulosis With DUSP22-IRF4 Rearrangement on Chromosome 6p25.3: A Case Report.
Pan PY; Liao JB; Hsieh SM; Tseng HW
Am J Dermatopathol; 2023 Jun; 45(6):391-396. PubMed ID: 36939126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
